In focus · trending topic

resistant bacterial infections

1 stories · following the connections

Melinta Therapeutics’ Phase 3 trials of Baxdela Document Challenges in Antibiotic Selection in Patients Treated for ABSSSI

By Nasdaq OMXMay 2, 2017, 1:39 PM UTC